Stitch Fix, Inc. - (SFIX) News
Filter SFIX News Items
SFIX News Results
|Loading, please wait...|
SFIX News Highlights
- SFIX's 30 day story count now stands at 21.
- Over the past 20 days, the trend for SFIX's stories per day has been choppy and unclear. It has oscillated between 1 and 16.
- The most mentioned tickers in articles about SFIX are FIX, LI and ROKU.
Latest SFIX News From Around the Web
Below are the latest news stories about STITCH FIX INC that investors may wish to consider to help them evaluate SFIX as an investment opportunity.
Stitch Fix, Etsy, and Other Retailers Weigh in on the SVB Meltdown
Despite having less exposure to the world of venture capital and tech start-ups, retail hasn't escaped unscathed from the closure of Silicon Valley Bank.
Stitch Fix no longer expects $40 million revolving credit commitment from Silicon Valley Bank to be available, but has enough cash for at least next 12 months
Online clothing company Stitch Fix Inc. (SFIX) said Monday it had a $100 million revolving credit agreement with Silicon Valley Bank, JPMorgan Chase and Citibank N.A. Silicon Valley Bank’s commitment was $40 million, which the company does not expect to remain available now the bank is in receivership. “At this time, the company has no plans to draw on the Amended Credit Agreement and reaffirms its estimate that its cash, cash equivalents, investment balances, and the borrowing available under its Amended Credit Agreement, if needed, will be sufficient to meet its working capital and capital expenditure needs for at least the next 12 months and beyond,” Stitch Fix said in a regulatory filing.
Hedge funds and C-suites: Illumina pops on Icahn news | Pro Recap
Here is your Pro Recap of the biggest news out of hedge funds and company top brass you may have missed in the past week. Illumina (NASDAQ:ILMN) shares rose sharply on word Carl Icahn is preparing to launch a proxy fight there, seeking three board seats, according to the Wall Street Journal. According to Icahn, the biotech company's acquisition of Grail costed shareholders $50 billion and is now costing the company $800 million annually.
Stitch Fix Stock Is Down 95% From Its High. Time to Buy?
Stitch Fix (NASDAQ: SFIX) posted its latest earnings report on March 7. In the second quarter of fiscal 2023, which ended on Jan. 28, the online apparel retailer's revenue fell 20% year over year to $412 million and missed analysts' estimates by $1 million. Could it be a deep value play for investors who are willing to ride out the near-term headwinds?
These Stocks Are Moving the Most Today: Tesla, Maxeon Solar, United Natural Foods, SoundHound, and More
Tesla stock receives a downgrade, Maxeon Solar issues a better-than-expected outlook, and United Natural Foods slashes guidance for 2023.
Piper Sandler analysts cite ‘foundational issues’ for Stitch Fix
The Yahoo Finance Live team discusses the latest outlook from analysts on Stitch Fix.
Hold Stitch Fix. It ‘Is Not the Stock You’re Looking for,’ Analyst Says.
Stitch Fix an online personal-styling company, “is not the stock you’re looking for,” according to analysts at Wedbush. Analyst Tom Nikic maintained his Neutral rating on the stock in a report Wednesday, after the company reported a sharp decline in fiscal second-quarter net revenue, a wider-than-expected loss, and a drop in its number of active clients. Shares of Stitch Fix fell 11% to $4.42 early Wednesday.
Roku Ropes In Stitch Fix's Dan Jedda As New CFO; The Former Amazon Veteran Succeeds Steve Louden
Dan Jedda will join Roku, Inc (NASDAQ: ROKU) as CFO, effective May 1. Jedda will succeed current CFO Steve Louden, who shared his exit plan in 2022. Since 2020, Jedda has been the CFO at Stitch Fix, Inc (NASDAQ: SFIX). Before Stitch Fix, Jedda worked at Amazon.Com Inc (NASDAQ: AMZN) for 15 years. Stitch Fix announced Jedda's departure on Tuesday in its Q2 earnings report. Also Read: Roku Q4 Earnings Highlights: Revenue, EPS Beat, Active Account Update, Roku Branded TVs, Q1 Guidance And More "As
Q2 2023 Stitch Fix Inc Earnings Call
Q2 2023 Stitch Fix Inc Earnings Call
Bed Bath & Beyond’s stock gives up gains after proceeds from Feb. equity offering rise, and CrowdStrike gains after earnings beat
Tesla's stock drops again, Fresh Track Therapeutics' shares soars upon initial clinical trial results